Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sky Energy Indonesia Tbk. (JSKY) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Sky Energy Indonesia Tbk.Trade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Sky Energy Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Sky Energy Indonesia Tbk. trades at Rp52 (market cap 105.69B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Sky Energy Indonesia Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.

JSKYSCPI
Market Cap
105.69B104.4B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SCPI
View details

About Sky Energy Indonesia Tbk.

PT Sky Energy Indonesia (the Entity) was established based on Notarial Deed No. 6, dated July 4, 2008 of Petrus Suandi Halim, S.H., notary in Jakarta. Initially the Entity engaged as distributor of solar modules and provider of System Integration technical services for the manufacture of Pembangkit Listrik Tenaga Surya (PLTS) On-grid and Off-grid types, including technical design, installation and maintenance. in 2009 the Entity cooperated with PT Hitachi High-Technologies Indonesia to establish an international-class solar module manufacturing facility. In the year of 2012, the Entity commenced the production of solar modules with a capacity of 10 MW. By 2016, The Entity has grown to become the largest producer of solar modules in Indonesia with capacity production of 100 MW for solar modules and 50 MW for solar cells.

Read more on JSKY

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI